Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Wall Street leaps as Nasdaq rallies 3% on boost from Big Tech, chipmakers

Published 07/12/2021, 09:56 pm
Updated 08/12/2021, 04:39 am
© Reuters. FILE PHOTO: A street sign for Wall Street is seen outside the New York Stock Exchange (NYSE) in New York City, New York, U.S., July 19, 2021. REUTERS/Andrew Kelly

By Devik Jain and Shreyashi Sanyal

(Reuters) -Wall Street's main indexes rallied strongly on Tuesday, with the Nasdaq surging 3% as investors piled onto beaten-down quality technology stocks, while Intel (NASDAQ:INTC) jumped after plans to take its self-driving car unit public.

The chip giant's decision to list Mobileye (F:0ME) in the United States in mid-2022 was met overwhelmingly, with its shares 4.5% higher. The Philadelphia SE Semiconductor index surged 5.0%, bouncing off a near one-month low hit in the previous session.

All of the 11 major S&P sectors advanced, with the information technology sector , which houses companies like Visa Inc (NYSE:V), Mastercard Inc (NYSE:MA), Salesforce.com (NYSE:CRM) Apple Inc (NASDAQ:AAPL) and Microsoft Corp (NASDAQ:MSFT), gaining 3.4%.

The Nasdaq has climbed nearly 4% so far this week, more than recovering all its losses suffered last week when the Federal Reserve's hawkish comments about speedier taper spurred bets about an early interest rate hike next year to curb surging inflation.

"The markets understand that a zero interest rate environment is not going to last forever, that the Fed is going to use a measured approach to raising rates and not just some dramatic balance upwards," said Kim Forrest, chief investment officer at Bokeh Capital Partners in Pittsburgh.

"This is a reflection of what is driving the market. Things that were on sale are being bought, especially those higher multiple stocks."

Optimistic comments from a top U.S. official about the nature of the Omicron variant and positive data on a COVID-19 drug's efficacy against the latest variant also boosted investors' sentiment.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Shares of Vir Biotechnology jumped 4.8% after British drugmaker GSK said an antibody-based COVID-19 therapy it is developing with Vir is effective against all mutations of the Omicron variant.

"It (Omicron) doesn't seem as devastating as prior variants and I think all of this is making us move out of the financial doldrums of COVID," Forrest said.

The CBOE volatility index, too, eased from a 10-month high hit last week.

At 12:07 p.m. ET, the Dow Jones Industrial Average was up 537.15 points, or 1.52%, at 35,764.18, the S&P 500 was up 96.81 points, or 2.11%, at 4,688.48, and the Nasdaq Composite was up 459.76 points, or 3.02%, at 15,684.91.

Shares of mega-cap tech stocks Meta Platforms, Google-owner Alphabet (NASDAQ:GOOGL), Tesla (NASDAQ:TSLA) Inc and Amazon (NASDAQ:AMZN) added between 2.0% and 3.1%.

Travel shares continued the momentum, with the S&P 1500 Airlines and the S&P 1500 Hotels, Restaurant and Leisure indexes rising 0.6% and 2.0% respectively.

American Airlines (NASDAQ:AAL) added 1.1% after the carrier announced the retirement of Chief Executive Officer Doug Parker.

Merck & Co fell 1.9% as Guggenheim downgraded the stock to "neutral" from "buy" after the drugmaker paused enrollment in two late-stage clinical trials testing its experimental drug for treatment and prevention of HIV-1.

Advancing issues outnumbered decliners by a 7.13-to-1 ratio on the NYSE and by a 4.70-to-1 ratio on the Nasdaq.

The S&P index recorded 34 new 52-week highs and no new low, while the Nasdaq recorded 40 new highs and 36 new lows.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.